Literature DB >> 15701278

Atypical white matter volume development in children following craniospinal irradiation.

Wilburn E Reddick1, John O Glass, Shawna L Palmer, Shingjie Wu, Amar Gajjar, James W Langston, Larry E Kun, Xiaoping Xiong, Raymond K Mulhern.   

Abstract

Most children with medulloblastoma (MB), the second most common pediatric brain tumor, have a 70% probability of survival. However, survivors who receive aggressive therapy are at significant risk of cognitive deficits that have been associated with lower volumes of normal-appearing white matter (NAWM). We hypothesized that cranial irradiation inhibited normal brain volume development in these survivors. We retrospectively analyzed 324 MRI studies of 52 patients with histologically proven MB treated with surgery and 35 to 40 Gy craniospinal irradiation, with or without chemotherapy. The volume of NAWM and that of cerebrospinal fluid were quantified from a single index section and compared with those of healthy, age-similar control subjects. A quadratic random coefficient model was used to identify trends in brain volume with increasing age. Patients treated for MB at younger ages demonstrated substantially less development of NAWM volume than did their healthy peers. Younger age at the time of irradiation and the need for a ventricular shunt were significantly associated with reduced NAWM volume. NAWM and craniospinal fluid volume differences between patients who had shunts and those without resolved over a period of four to five years. NAWM volume is known to be associated with neurocognitive test performance, which shows deficiencies after cranial irradiation early in life. Therefore, volumetric monitoring of brain development can be used to guide the care of survivors, assess the toxicity of previous and current clinical trials, and aid in the design of therapies that minimize toxicity.

Entities:  

Mesh:

Year:  2005        PMID: 15701278      PMCID: PMC1871625          DOI: 10.1215/S1152851704000079

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  23 in total

1.  Brain development during childhood and adolescence: a longitudinal MRI study.

Authors:  J N Giedd; J Blumenthal; N O Jeffries; F X Castellanos; H Liu; A Zijdenbos; T Paus; A C Evans; J L Rapoport
Journal:  Nat Neurosci       Date:  1999-10       Impact factor: 24.884

2.  Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy.

Authors:  J Schatz; J H Kramer; A Ablin; K K Matthay
Journal:  Neuropsychology       Date:  2000-04       Impact factor: 3.295

3.  Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study.

Authors:  Elizabeth R Sowell; Doris A Trauner; Anthony Gamst; Terry L Jernigan
Journal:  Dev Med Child Neurol       Date:  2002-01       Impact factor: 5.449

4.  Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation.

Authors:  W E Reddick; J M Russell; J O Glass; X Xiong; R K Mulhern; J W Langston; T E Merchant; L E Kun; A Gajjar
Journal:  Magn Reson Imaging       Date:  2000-09       Impact factor: 2.546

Review 5.  Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach.

Authors:  Robert W Butler; Donna R Copeland
Journal:  J Int Neuropsychol Soc       Date:  2002-01       Impact factor: 2.892

6.  Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

Authors:  S L Palmer; O Goloubeva; W E Reddick; J O Glass; A Gajjar; L Kun; T E Merchant; R K Mulhern
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

7.  Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss.

Authors:  R K Mulhern; S L Palmer; W E Reddick; J O Glass; L E Kun; J Taylor; J Langston; A Gajjar
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

8.  Neurocognitive deficits in medulloblastoma survivors and white matter loss.

Authors:  R K Mulhern; W E Reddick; S L Palmer; J O Glass; T D Elkin; L E Kun; J Taylor; J Langston; A Gajjar
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

9.  Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer.

Authors:  S J Thompson; L Leigh; R Christensen; X Xiong; L E Kun; R L Heideman; W E Reddick; A Gajjar; T Merchant; C H Pui; M M Hudson; R K Mulhern
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

10.  Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.

Authors:  M D Ris; R Packer; J Goldwein; D Jones-Wallace; J M Boyett
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

View more
  45 in total

1.  Visualization and segmentation of reciprocal cerebrocerebellar pathways in the healthy and injured brain.

Authors:  Nicole Law; Mark Greenberg; Eric Bouffet; Suzanne Laughlin; Michael D Taylor; David Malkin; Fang Liu; Iska Moxon-Emre; Nadia Scantlebury; Jovanka Skocic; Donald Mabbott
Journal:  Hum Brain Mapp       Date:  2015-04-14       Impact factor: 5.038

Review 2.  Advanced imaging in paediatric neuroradiology.

Authors:  Mehmet Kocak
Journal:  Pediatr Radiol       Date:  2009-06

3.  Processing speed in children treated for brain tumors: effects of radiation therapy and age.

Authors:  Lisa A Jacobson; E Mark Mahone; Keith O Yeates; M Douglas Ris
Journal:  Child Neuropsychol       Date:  2018-04-06       Impact factor: 2.500

4.  Brain Damage and Patterns of Neurovascular Disorder after Ionizing Irradiation. Complications in Radiotherapy and Radiation Combined Injury.

Authors:  Nikolai V Gorbunov; Juliann G Kiang
Journal:  Radiat Res       Date:  2021-07-01       Impact factor: 2.841

5.  Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.

Authors:  Wilburn E Reddick; Zuyao Y Shan; John O Glass; Susan Helton; Xiaoping Xiong; Shengjie Wu; Melanie J Bonner; Scott C Howard; Robbin Christensen; Raja B Khan; Ching-Hon Pui; Raymond K Mulhern
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

6.  Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma.

Authors:  Tara M Brinkman; Wilburn E Reddick; Joshua Luxton; John O Glass; Noah D Sabin; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

7.  Cognitive Performance, Aerobic Fitness, Motor Proficiency, and Brain Function Among Children Newly Diagnosed With Craniopharyngioma.

Authors:  Heather M Conklin; Kirsten K Ness; Jason M Ashford; Matthew A Scoggins; Robert J Ogg; Yuanyuan Han; Yimei Li; Julie A Bradley; Frederick A Boop; Thomas E Merchant
Journal:  J Int Neuropsychol Soc       Date:  2019-04       Impact factor: 2.892

8.  A prospective study of cerebral, frontal lobe, and temporal lobe volumes and neuropsychological performance in children with primary brain tumors treated with cranial radiation.

Authors:  Harold Agbahiwe; Arif Rashid; Alena Horska; E Mark Mahone; Doris Lin; Todd McNutt; Kenneth Cohen; Kristin Redmond; Moody Wharam; Stephanie Terezakis
Journal:  Cancer       Date:  2016-08-29       Impact factor: 6.860

9.  Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.

Authors:  Wilburn E Reddick; Delaram J Taghipour; John O Glass; Jason Ashford; Xiaoping Xiong; Shengjie Wu; Melanie Bonner; Raja B Khan; Heather M Conklin
Journal:  Pediatr Blood Cancer       Date:  2014-01-25       Impact factor: 3.167

10.  Slower processing speed after treatment for pediatric brain tumor and acute lymphoblastic leukemia.

Authors:  Lisa S Kahalley; Heather M Conklin; Vida L Tyc; Melissa M Hudson; Stephanie J Wilson; Shengjie Wu; Xiaoping Xiong; Pamela S Hinds
Journal:  Psychooncology       Date:  2013-02-28       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.